Liposomal Lipopolysaccharide Initiates TRIF-Dependent Signaling Pathway Independent of CD14. by Watanabe, Sachiko et al.
Title Liposomal Lipopolysaccharide Initiates TRIF-DependentSignaling Pathway Independent of CD14.
Author(s)Watanabe, Sachiko; Kumazawa, Yoshio; Inoue, Joe




© 2013 Watanabe et al. This is an open-access article
distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the




Liposomal Lipopolysaccharide Initiates TRIF-Dependent
Signaling Pathway Independent of CD14
Sachiko Watanabe1., Yoshio Kumazawa1, Joe Inoue1,2*.
1Department of Biosciences, School of Science and Graduate School of Science, Kitasato University, Sagamihara, Kanagawa, Japan, 2Department of Immunology and Cell
Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
Abstract
Lipopolysaccharide (LPS) is recognized by CD14 with Toll-like receptor 4 (TLR4), and initiates 2 major pathways of TLR4
signaling, the MyD88-dependent and TRIF-dependent signaling pathways. The MyD88-dependent pathway induces
inflammatory responses such as the production of TNF-a, IL-6, and IL-12 via the activation of NFkB and MAPK. The TRIF-
dependent pathway induces the production of type-I IFN, and RANTES via the activation of IRF-3 and NFkB, and is also
important for the induction of adaptive immune responses. CD14 plays a critical role in initiating the TRIF-dependent
signaling pathway response to LPS, to support the internalization of LPS via endocytosis. Here, we clearly demonstrate that
intracellular delivery of LPS by LPS-formulated liposomes (LPS-liposomes) initiate only TRIF-dependent signaling via clathrin-
mediated endocytosis, independent of CD14. In fact, LPS-liposomes do not induce the production of TNF-a and IL-6 but
induce RANTES production in peritoneal macrophages. Additionally, LPS-liposomes could induce adaptive immune
responses effectively in CD14-deficient mice. Collectively, our results strongly suggest that LPS-liposomes are useful as
a TRIF-dependent signaling-based immune adjuvant without inducing unnecessary inflammation.
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Introduction
Lipopolysaccharide (LPS) recognition has been well studied,
and CD14 along with Toll-like receptor 4 (TLR4) forms the best-
characterized LPS sensor [1–12]. CD14 was the first identified
Pattern Recognition Receptor that binds directly to LPS [7], and
is known to chaperone LPS to the TLR4 signaling pathway
[13,14]. TLR4 signaling is also well studied, and it is known that 2
major signaling pathways, the MyD88-dependent and TIR-
domain-containing adapter-inducing interferon-b (TRIF)-depen-
dent signaling pathways, are activated when TLR4 recognizes LPS
[4–6,15]. The MyD88-dependent pathway is activated at the
plasma membrane and induces inflammatory responses such as
the production of TNF-a, IL-6, and IL-12 via the activation of
mitogen-activated protein kinase (MAPK) and nuclear factor
kappa B (NFkB) in the early phase. On the other hand, the TRIF-
dependent pathway is activated when LPS is taken into the
endosome [16,17]. In support of this, Kagan et al. used endocytosis
inhibitors and showed that endocytosis of TLR4 with LPS initiates
the TRIF-dependent pathway in early endosomes [18]. TRIF-
dependent signaling induces the production of type-I interferon
(IFN), which activates anti-viral responses, chemokines such as
regulated upon activation, normal T cell expressed and secreted
(RANTES; also known as CCL5), and to some extent, interleukin
(IL)-6 via the activation of IFN regulatory factor (IRF)-3 and
NFkB in the late phase [16,19].
With regard to the relationship between the TRIF-dependent
pathway and CD14, Zhengfan et al. showed, using Heedless
mutation mice whose phenotype was positionally ascribed to
a premature stop codon in cd14, that CD14 is required for the
TRIF-dependent pathway [20]. Recently, it has been reported
that CD14 controls the LPS-induced endocytosis of TLR4
through the tyrosine kinase Syk and its downstream effector
phospholipase C (PLC) c2 [21]. Taken together, the initiation of
the TRIF-dependent signaling pathway by LPS requires endocy-
tosis and CD14 supports this internalization of LPS. Additionally,
CD14 also enhances the MyD88-dependent pathway activated
with the plasma membrane response to LPS [10]. CD14-deficient
mice showed resistance to endotoxin shock induced by LPS [9].
Therefore, CD14 plays a critical role in response to LPS.
As a candidate for a vaccine adjuvant, LPS can strongly induce
and modulate adaptive immune responses, however, the LPS-
initiated MyD88-dependent pathway induces the production of
inflammatory cytokines such as TNF-a, IL-6, and IL-12, and this
unnecessary inflammation sometimes causes septic shock with
a cytokine storm [22]. On the other hand, the intracellular
recognition of LPS initiates the TRIF-dependent pathway, which
is important for the induction of adaptive immune responses
[23,24]. Hence, adjuvants that activate only the TRIF-dependent
pathway are likely be safer; however, there is no tool to activate
only the TRIF-dependent pathway response to LPS.
In this study, we newly prepared LPS-formulated liposomes
(LPS-liposomes) to deliver the LPS directly to the endosome. We
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hypothesized that direct delivery of LPS to the endosome would
activate the TRIF-dependent pathway and thereby form an
effective immune adjuvant. As expected, LPS-liposomes were
internalized via clathrin-mediated endocytosis and activated the
TRIF-dependent pathway independent of CD14, but not the
MyD88-dependent pathway. These results suggest that CD14 is
required only for the uptake of LPS via endocytosis. Additionally,
antigen-encapsulating LPS-liposomes could induce antigen-specif-
ic adaptive immune responses effectively in both wild-type and
CD14-deficient mice. Taken together, LPS-liposomes can be
useful as an immune adjuvant to induce protective immunity
without inducing unnecessary inflammation.
Materials and Methods
Mice
Wild-type C57BL/10ScSn (WT), TLR4-deficient C57BL/
10ScN (TLR42/2) mice, and CD14-deficient C57BL/10
(CD142/2) mice were obtained from the Max-Planck Institute
for Immunobiology and Epigenetics (Freiburg, Germany). All
mice were used at 8–12 weeks of age. All mice were housed in
a specific pathogen-free environment at the Kitasato University
School of Science in strict accordance with the Institutional
Animal Care and Use Committee (IACUC) Guidelines. This study
was carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of Kitasato
University School of Science. The protocol was approved by the
Committee on the Ethics of Animal Experiments of Kitasato
University School of Science (Permit Number: SA1017). All efforts
were made to minimize suffering.
Reagents
Highly purified LPS from S. abortus equi was kindly provided by
Dr. Chris Galanos (Max-Planck Institute for Immunobiology and
Epigenetics). Alexa488-conjugated LPS, rhodamine-conjugated
dextran (MW, 10,000 Da), and rhodamine-conjugated transferrin
were purchased from Life Technologies Corporation (Tokyo,
Japan). Brewer’s thioglycollate was purchased from BD Bios-
ciences (Franklin Lakes, NJ). Anti-IRF3, anti-phospho-IRF3
(Ser396), anti-inhibitor of kappa B (IkB) a anti-phospho-IkBa
(Ser32), anti- interleukin-1 receptor-associated kinase 1 (IRAK1),
anti-glyceraldehyde phosphate dehydrogenase (GAPDH), anti-
phospho-stress-activated protein kinase/c-Jun N-terminal kinase
(SARK/JNK) (Thr183/Tyr185), anti-SARK/JNK, anti-phospho-
p38 MAPK (Thr180/Tyr182), and anti-p38 MAPK antibodies for
immunoblot analysis were purchased from Cell Signaling Tech-
nology (Danvers, MA). AP-conjugated goat anti-mouse IgG
antibodies for the enzyme-linked immunosorbent assay (ELISA)
were purchased from Invitrogen (Carlsbad, CA). 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) and 1,2-dipalmitoyl- sn-
glycero-3-phosphoethanolamine-N-[methoxy (polyethylene gly-
col)-2000] (DPPE-PEG) were obtained from Avanti Polar Lipids
(Birmingham, AL). Ovalbumin (OVA) and chlorpromazine
hydrochloride (CPZ) were obtained from Sigma (St. Louis, MO).
Preparation of Liposomes
DOTAP was dissolved in chloroform, vacuum-desiccated, and
hydrated by vortexing with sterilized phosphate-buffered saline
(PBS) for liposomes, and LPS or Alexa488-conjugated LPS (10–
100 mg/mL) in sterilized PBS for LPS-liposomes, and diluted in
PBS to obtain a final LPS concentration of 1 mg/mL. LPS (1 mg/
mL), LPS-lipoosmes (LPS concentration of 1 mg/mL) and
liposomes (same DOTAP concentration of LPS-liposomes) was
diluted in the medium were used for the experiments. For the
encapsulation of OVA, DOTAP and DPPE-PEG were dissolved
in chloroform, vacuum-desiccated, and hydrated by vortexing with
a mixture of LPS (1 mg/mL) and OVA (1 mg/mL) in PBS, and
diluted in PBS to obtain a final concentration of 100 mg/mL.
Following hydration, the dispersion was sonicated for 1 min in
a bath sonicator (Bioruptor, Cosmo Bio, Tokyo, Japan).
Cell Culture and Cytokine Determination
2 mL of 4% Brewer’s thioglycollate medium was injected
intraperitoneally. Thioglycollate-elicited peritoneal macrophages
were collected 4 days later using cold Hank’s balanced salt
solution. Thioglycollate-elicited peritoneal macrophages from WT
or CD142/2 mice were cultured in 96-well plates (16105 cells per
well) with LPS or LPS-liposomes (10 ng/mL) for 2 h (TNF-a) or
24 h (IL-6, and RANTES). In case of using endocytosis inhibitor,
thioglycollate-elicited peritoneal macrophages from WT or
CD142/2 mice were cultured in 96-well plates (26105 cells per
well) with LPS or LPS-liposomes (100 ng/mL) in the presence or
absence of CPZ (0–50 mM). After 2 h (TNF-a), medium was
changed and incubated for 24 h (IL-6, and RANTES). TNF-a,
and IL-6 were measured by ELISA using the OptEIA mouse
cytokine detection kit (BD Biosciences). RANTES was measured
by ELISA using the Quantikine mouse RANTES ELISA Kit
(R&D Systems, Minneapolis, MN). Thioglycollate-elicited perito-
neal macrophages were incubated in RPMI-1640 medium
supplemented with 10% fetal calf serum (FCS), 100 U/mL
penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine, and
5610–5 M 2-mercaptoethanol.
Flow Cytometry
Thioglycollate-elicited peritoneal macrophages from WT mice
were cultured with Alexa488-conjugated LPS or LPS-liposomes
(100 ng/mL) for 90 min. The cells were analyzed using a flow
cytometer EPICS ELITE (Beckman Coulter, CA), and WinMDI
for analysis software [25].
Confocal Laser Scanning Microscopy
Thioglycollate-elicited peritoneal macrophages from WT mice
were cultured with Alexa488-conjugated LPS or LPS-liposomes
(100 ng/mL) for 90 min. In order to visualize clathrin-mediated
endocytosis and macropinocytosis, the cells were incubated with
rhodamine-conjugated transferrin (10 mg/mL) or rhodamine-
conjugated dextran (100 mg/mL). The localization of fluorescence
was determined by confocal laser scanning microscopy (Carl Zeiss,
Jena, Germany) [26].
Immunoblot Analysis
Thioglycollate-elicited peritoneal macrophages (16106 cells)
from WT mice were cultured with LPS or LPS-liposomes
(100 ng/mL) for 0–120 min. Cells were lysed with ice-cold RIPA
lysis buffer containing protease inhibitors, and the extracts were
subjected to immunoblot analysis. Immunoblot analysis was
performed using anti-IRF3, anti-phospho-IRF3 (Ser396), anti-
IkBa, anti-phospho-IkBa (Ser32), anti-IRAK1, anti-GAPDH,
anti-pJNK (Thr183/Tyr185), anti-JNK, anti-pp38 MAPK
(Thr180/Tyr182), and anti-p38 MAPK antibodies, visualized
with HRP conjugate substrate system or an enhanced chemilu-
minescence detection system. Band intensity was quantified with
Image J 1.45.
OVA-specific Antibody Determination
WT or CD142/2 mice were immunized with LPS plus OVA,
or LPS-OVA-liposomes (10 mg each per mouse, intravenous) and
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boosted after 2 weeks. After a further 2 weeks, sera were harvested
and poured into an OVA-coated ELISA-plate, and incubated
overnight. Following washes with PBS containing 0.05% Tween-
20, the wells were treated with AP-conjugated-anti-mouse IgG for
2 h. Following washes, an enzyme reaction was performed using p-
nitrophenyl phosphate as the substrate. The absorbance at
405 nm (with a reference at 540 nm) was measured using a Bio-
Rad Model 550 Microplate Reader (Bio-Rad, Hercules, CA), as
described previously [27–30].
Statistical Analysis
The paired Student’s t test was used to compare paired groups.
P values ,0.05 were considered significant.
Results
Internalization of LPS by Liposomes via Clathrin-
mediated Endocytosis
First, we examined the uptake of LPS and LPS-liposomes by
macrophages using Alexa488-conjugated LPS. The uptake of
LPS-liposomes by macrophages was more efficient than that of
LPS (Fig. 1A). It is reported that CD14-dependent internalization
of LPS depended on 2 major endocytotic pathways, the
macropinocytic pathway and the clathrin-mediated pathway
[31,32]. Therefore, we next examined the route of internalization
of LPS and LPS-liposomes using fluorescence-labeled dextran to
trace the macropinocytic pathway, and fluorescence-labeled
transferrin to trace the clathrin-mediated pathway [33]. As shown
in Fig. 1B, Alexa488-labeled LPS partially co-localized with
rhodamine-labeled dextran; however, the localization of LPS-
liposomes did not occur or very few. The percentage of co-
localized cells was also significantly decreased in macrophages
treated with LPS-liposomes. In case of the clathrin-mediated
pathway, the fluorescence of both LPS and LPS-liposomes
overlapped with rhodamine-labeled transferrin, and the percent-
age of co-localized cells was significantly increased in macrophages
treated with LPS-liposomes (Fig. 1C). These results suggest that
internalization of LPS was mediated by both the macropinocytic
pathway and the clathrin-mediated pathway, and that LPS-
liposomes were efficiently internalized mainly via the clathrin-
mediated pathway.
LPS-liposomes Induce the TRIF-dependent Signaling
Pathway but not the MyD88-dependent Signaling
Pathway
It has been reported that the activation of NFkB in the early
phase is induced by MyD88-dependent signaling, and the
activation of IRF-3 and NFkB in the late phase is induced by
TRIF-dependent signaling [17]. Additionally, the TRIF-depen-
dent pathway requires the endocytosis of TLR4 with LPS [18].
Therefore, we next examined the activation of NFkB and IRF-
3 by LPS and LPS-liposomes. IRF-3 activation was detected by its
phosphorylation, and NFkB activation was detected by the
degradation and phosphorylation of IkBa, which inhibits NFkB
activation. As shown in Figure 2A, the phosphorylation of IRF-3
was induced by both LPS and LPS-liposomes. Furthermore, the
phosphorylation of IRF-3 was significantly enhanced and long-
lasting upon LPS-liposomes treatment compared with LPS. In the
case of IkBa, degradation and phosphorylation were only detected
in response to LPS (Fig. 2B). We also examined the activation of
IRAK1, an important molecule in the MyD88-dependent
pathway, and the activation of MAPK. IRAK1 activation was
measured by its degradation, and it was significantly detected in
response to LPS compared with LPS-liposomes (Fig. 2C). The
activation of MAPK was also induced by LPS; however, it was
very weak in response to LPS-liposomes (Fig. 2C). These results
strongly suggest that LPS-liposomes activate only the TRIF-
dependent signaling pathway.
LPS-liposomes Induce RANTES Production but not TNF-
a and IL-6 Production in Macrophages from WT and
CD142/2 Mice
Next, we examined the production of inflammatory cytokines
and chemokines, which are induced via the MyD88-dependent
and TRIF-dependent pathways. MyD88-dependent cytokines
such as TNF-a and IL-6 were highly produced by WT
macrophages in response to LPS (Fig. 3A). By contrast, LPS-
liposomes did not induce these inflammatory cytokines. The
production of RANTES, a TRIF-dependent chemokine, was
induced by both LPS and LPS-liposomes (Fig. 3A). The pro-
duction of inflammatory cytokines and chemokines were com-
pletely abolished in TLR42/2 macrophages in response to both
LPS and LPS-liposomes (Fig. 3B). Surprisingly, LPS-liposomes
could induce RANTES production from CD142/2 macrophages,
although CD142/2 macrophages did not exhibit any cytokine and
chemokine response to LPS (Fig. 3C). Furthermore, LPS-
liposomes could induce the phosphorylation of IRF-3 significantly
compared with LPS (Fig. S1). These results suggest that LPS-
liposomes activate the TLR4-mediated TRIF-dependent pathway
independent of CD14.
Clathrin-mediated Endocytosis of LPS Induces RANTES
Production in Macrophages from WT and CD142/2 Mice
The TRIF-dependent pathway is initiated by the endocytosis of
TLR4 with LPS [18]. Therefore, we examined the influence of an
endocytosis inhibitor, CPZ, which inhibits the clathrin-mediated
endocytosis pathway by which LPS and LPS-liposomes were
internalized. As shown in Fig. 4A, LPS-induced TNF-aproduction
was not affected by CPZ at all. The production of IL-6 and
RANTES was affected partially. By contrast, LPS-liposome-
induced RANTES production was completely inhibited by CPZ
in WT and CD142/2 macrophages (Fig. 4A,B). Moreover, the
difference was not observed in cell viability at least 50 mM of CPZ
(Fig. S2). These results strongly suggest that clathrin-mediated
endocytosis is required to initiate the TRIF-dependent pathway
for both LPS and LPS-liposomes, and that CD14 supports this
clathrin-mediated endocytosis in the case of LPS.
LPS-liposomes Enhances Antigen-specific IgG Production
Independent of CD14
The activation of the TRIF-dependent pathway by the in-
tracellular recognition of LPS is important for the induction of
adaptive immune responses [23,24,34]. Therefore, we prepared
ovalbumin (OVA)-encapsulating LPS-liposomes (LPS-OVA-lipo-
somes) to examine the induction of antigen-specific adaptive
immune responses in WT and CD142/2 mice. Mice were
immunized with LPS plus OVA or LPS-OVA-liposomes and
boosted after 2 weeks. After a further 2 weeks, sera were harvested
and OVA-specific antibodies were examined by ELISA. As shown
in Figure 5, the production of OVA-specific IgG was significantly
enhanced by LPS-OVA-liposomes in both WT and CD142/2
mice compared with LPS plus OVA. In LPS plus OVA
immunization, the antibody response was decreased significantly
in CD142/2 mice. These results suggest that CD14 is important
for inducing the adaptive immune response by LPS, and LPS-
OVA-liposomes effectively induce antigen-specific immune re-
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Figure 1. Internalization of lipopolysaccharide (LPS) by liposomes via clathrin-mediated endocytosis. (A) Thioglycollate-elicited
peritoneal macrophages from wild-type (WT) mice were cultured with PBS or Alexa488-conjugated LPS (100 ng/mL) or Alexa488-conjugated LPS-
Liposomal LPS Activate Only TRIF-Dependent Pathway
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e60078
sponses via the activation of the TRIF-dependent pathway
independent of CD14 in vivo.
Discussion
We newly prepared LPS-formulated liposomes to deliver the
LPS directly to the endosome and showed that only the TRIF-
dependent pathway was activated, independent of CD14. CD14
plays a critical role in LPS recognition and chaperones LPS to the
TLR4 signaling pathway; therefore CD142/2 mice showed
resistance to endotoxin shock induced by LPS [9]. On the other
hand, it has been reported that LPS from rough colonies (R-LPS),
which lacks an O-polysaccharide chain of LPS, and Lipid A can
induce inflammatory cytokines such as TNF-a in the absence of
CD14 [20,35]. However, TRIF-dependent cytokines such as I-
IFN are not produced in the absence of CD14 even with R-LPS
and Lipid A stimulation [20]. These studies indicate that CD14 is
not indispensable for the MyD88-dependent pathway but required
for the TRIF-dependent pathway. It has also been reported that
CD14 controls the LPS-induced endocytosis of TLR4 to initiate
the TRIF-dependent signaling pathway [21]. From our findings,
LPS-liposomes could induce RANTES production in CD142/2
macrophages and also induce effective immune responses in
CD142/2 mice (Figs. 3C, 5 and Fig. S1). Additionally, clathrin-
mediated endocytosis of LPS was critically important for initiating
the TRIF-dependent signaling pathway (Fig. 4). These results
suggest that CD14 is not indispensable for TLR4 signaling, but
endocytosis is essential.
liposomes (100 ng/mL) for 90 min. LPS uptake by macrophages was analyzed by flow cytometry. PBS treated macrophages were overlaid as control
(gray histograms). Mean fluorescence intensity (MFI) are average of three independent experiments. The values represent means6 S.E.M *P,0.05. (B)
and (C) Thioglycollate-elicited peritoneal macrophages from WT mice were cultured with Alexa488-conjugated LPS or LPS-liposomes (100 ng/mL) for
90 min with or without rhodamine-conjugated transferrin (10 mg/mL) or rhodamine-conjugated dextran (100 mg/mL). The localization of
fluorescence was determined by confocal laser scanning microscopy. Scale bar: 10 mm. Histogram of the values for co-localized cells (cells with yellow
signals) as a percent of the total Alexa488+ cells. 100 cells (Alexa488+ cells) were counted for each set and calculated on three separate experiments.
The values represent means 6 S.E.M *P,0.05.
doi:10.1371/journal.pone.0060078.g001
Figure 2. LPS-liposomes induce the TRIF-dependent signaling
pathway but not the MyD88-dependent signaling pathway.
Thioglycollate-elicited peritoneal macrophages (16106 cells) from WT
mice were stimulated with LPS (100 ng/mL) or LPS-liposomes (100 ng/
mL) for 0–120 min. The cells were then lysed and the extracts
immunoblotted with anti-IRF3 (A), anti-IkBa antibodies (B), or anti-IRAK
and anti-MAPK antibodies (C). Data are average of three independent
experiments and band intensity was quantified with Image J 1.45. The
values represent means 6 S.E.M *P,0.05.
doi:10.1371/journal.pone.0060078.g002
Figure 3. LPS-liposomes induce RANTES production but not
TNF-a and IL-6 production in macrophages from WT and
CD142/2mice. Thioglycollate-elicited peritoneal macrophages (16105
cells) from WT (A), TLR42/2 (B), or CD142/2 mice (C) were cultured with
LPS or LPS-liposomes (10 ng/mL) for 2 h (TNF-a) or 24 h (IL-6, and
RANTES). Cytokine levels were determined by ELISA. PBS was control for
LPS and liposomes was control for LPS-liposomes (Open columns). Data
are average of three independent experiments. The values represent
means 6 S.E.M *P,0.05 (LPS vs. LPS-liposomes).
doi:10.1371/journal.pone.0060078.g003
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LPS-liposomes induce the TRIF-dependent signaling pathway
efficiently, but not the MyD88-dependent signaling pathway
(Fig. 2, 3). This is because LPS is highly concentrated in the
liposomes and escape recognition by LPS sensors at the plasma
membrane. Liposomes are also useful as drug carriers to efficiently
deliver drugs, DNA, and immune stimulatory molecules into the
cell via endocytosis [36–39]. It does not leak in general, LPS-
liposomes deliver LPS into the cell more efficiently (Fig. 1). This
uptake of highly concentrated LPS initiates the TRIF-dependent
signaling pathway in endosomes. It has been reported that
liposomes could spatiotemporally regulate CpG oligodeoxynucleo-
tide-induced TLR9 signaling [40]. CpG-liposome complexes are
retained for long periods in endosomal vesicles and induce robust
IFN production via IRF-7 activation. Our LPS-liposomes is also
manipulated for endosomal retention and regulates the intracel-
lular recognition of LPS and TLR4 signaling, especially the TRIF-
dependent signaling pathway. In fact, we detected the potentiation
and extension of IRF-3 activation by LPS-liposomes (Fig. 2A), and
it is predicted that this activation depends on the endosomal
retention of LPS regulated by liposomes.
Recently, TLR ligands have been considered as candidates for
immune adjuvants, given their ability to induce strong immune
responses. However, these strong immune responses also induce
unnecessary inflammation, which is sometimes fatal. Thus, it is
very difficult to develop effective and safe immune adjuvants. It
has recently been reported that TRIF-biased TLR4 agonists can
be used as vaccine adjuvants with low toxicity [24]. Immunization
with these agonists tends to activate the TRIF-dependent pathway
rather than the MyD88-dependent pathway; therefore, the
induction of unnecessary inflammation is minimal. It is also
reported that the expression of MHC-class II and co-stimulatory
molecules such as CD40, CD80, and CD86, which are important
for the stimulation of naı¨ve T cells to differentiate into effector T
helper cells, could be induced by LPS in MyD882/2 antigen-
presenting cells, suggesting that the TRIF-dependent pathway
plays a critical role in the induction of adaptive immunity [34].
These studies also support our observations that LPS-liposomes
could serve as safe and effective immune adjuvants. Furthermore,
the LPS-liposome can encapsulate antigen and induce antibody
responses more effectively than LPS plus antigen (Fig. 5).
In conclusion, the LPS-liposome is useful as a TRIF-dependent
signaling-based immune adjuvant that effectively induces adaptive
immune responses without inducing unnecessary inflammation.
The LPS-liposome is the first tool to induce only the TRIF-
dependent pathway together with allowing antigen encapsulation,
and may be useful as an immune adjuvant to induce protective
immunity.
Supporting Information
Figure S1 LPS-liposomes induce the activation of IRF-3
in macrophages from CD142/2 mice. Thioglycollate-
elicited peritoneal macrophages (16106 cells) from CD142/2
mice were stimulated with LPS (100 ng/mL) or LPS-liposomes
(100 ng/mL) for 0–120 min. The cells were then lysed and the
extracts immunoblotted with anti-IRF3 and anti-pIRF3 anti-
bodies. Data are average of three independent experiments and
Figure 4. Clathrin-mediated endocytosis of LPS induces
RANTES production in macrophages from WT and CD142/2
mice. Thioglycollate-elicited peritoneal macrophages (26105 cells)
from WT (A) or CD142/2 mice (B) were cultured with LPS or LPS-
liposomes (100 ng/mL) in the presence or absence of CPZ (0–50 mM).
After 2 h (TNF-a), medium was changed and incubated for 24 h (IL-6,
and RANTES). Cytokine levels were determined by ELISA. Data are
average of three independent experiments. The values represent means
6 S.E.M *P,0.05.
doi:10.1371/journal.pone.0060078.g004
Figure 5. LPS-liposomes enhance antigen-specific IgG pro-
duction independent of CD14. WT and CD142/2 mice were
immunized with LPS plus OVA or LPS-OVA-liposomes (10 mg each per
mouse, intravenous), and boosted after 2 weeks. After a further 2
weeks, sera were harvested and OVA-specific IgG levels were de-
termined by ELISA. Data are averages of two independent experiments.
n= 528 animals per group. The values represent means 6 S.E.M
*P,0.05.
doi:10.1371/journal.pone.0060078.g005
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band intensity was quantified with Image J 1.45. The values
represent means 6 S.E.M *P,0.05.
(TIF)
Figure S2 Cell viability of macrophages treated with
CPZ. Thioglycollate-elicited peritoneal macrophages (26105 cells)
from WT mice were cultured in the presence or absence of CPZ
(0–100 mM). After 2 h, medium was changed and incubated for
24 h. Cell viability was examined by Cell-titer Glo (Promega,
Japan). Data are average of three independent experiments. The
values represent means 6 S.E.M *P,0.05 (0 mM vs 100 mM ).
(TIF)
Text S1 Materials and Methods.
(DOCX)
Author Contributions
Conceived and designed the experiments: JI. Performed the experiments:
JI SW. Analyzed the data: JI SW. Contributed reagents/materials/analysis
tools: JI YK. Wrote the paper: JI.
References
1. Beutler B (2002) TLR4 as the mammalian endotoxin sensor. Curr Top
Microbiol Immunol 270: 109–120.
2. Miller SI, Ernst RK, Bader MW (2005) LPS TLR4 and infectious disease
diversity. Nat Rev Microbiol 3: 36–46.
3. Miyake K (2004) Innate recognition of lipopolysaccharide by Toll-like receptor
4-MD-2. Trends Microbiol 12: 186–192.
4. Yamamoto M, Akira S (2009) Lipid A receptor TLR4-mediated signaling
pathways. Adv Exp Med Biol 667: 59–68.
5. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol 11: 373–384.
6. Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate
receptors in infection and immunity. Immunity 34: 637–650.
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14,
a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science 249: 1431–1433.
8. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW et al. (1993) Transgenic mice
expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl
Acad Sci U S A 90: 2380–2384.
9. Haziot A, Ferrero E, Ko¨ntgen F, Hijiya N, Yamamoto S et al. (1996) Resistance
to endotoxin shock and reduced dissemination of gram-negative bacteria in
CD14-deficient mice. Immunity 4: 407–414.
10. Gangloff SC, Za¨hringer U, Blondin C, Guenounou M, Silver J et al. (2005)
Influence of CD14 on ligand interactions between lipopolysaccharide and its
receptor complex. J Immunol 175: 3940–3945.
11. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR et al. (1996)
Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin
Invest. 98: 1533–1538.
12. Kim JI, Lee CJ, Jin MS, Lee CH, Paik SG et al. (2005) Crystal structure of
CD14 and its implications for lipopolysaccharide signaling. J Biol Chem. 280:
11347–11351.
13. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ (2001)
Lipopolysaccharide is in close proximity to each of the proteins in its membrane
receptor complex transfer from CD14 to TLR4 and MD-2. J Biol Chem 276:
21129–21135.
14. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R et al. (2000) Divergent
response to LPS and bacteria in CD14-deficient murine macrophages.
J Immunol 165: 4272–4280.
15. Jiang Z, Georgel P, Du X, Shamel L, Sovath S et al. (2005) CD14 is required for
MyD88-independent LPS signaling. Nat Immunol 6: 565–570.
16. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T et al. (2003) Role of
adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Science 301: 640–643.
17. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K et al. (2003) TRAM is
specifically involved in the Toll-like receptor 4-mediated MyD88-independent
signaling pathway. Nat Immunol 4: 1144–1150.
18. Kagan JC, Su T, Horng T, Chow A, Akira S et al. (2008) TRAM couples
endocytosis of Toll-like receptor 4 to the induction of interferon-b. Nat Immunol
9: 361–368.
19. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A et al. (2003) LPS-
TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM
and TRIF. J Exp Med 198: 1043–1055.
20. Jiang Z, Georgel P, Du X, Shamel L, Sovath S et al. (2005) CD14 is required for
MyD88-independent LPS signaling. Nat Immunol 6: 565–570.
21. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R et al. (2011) CD14
controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147: 868–880.
22. Puneet P, McGrath MA, Tay HK, Al-Riyami L, Rzepecka J et al. (2011) The
helminth product ES-62 protects against septic shock via Toll-like receptor 4-
dependent autophagosomal degradation of the adaptor MyD88. Nat Immunol
12: 344–351.
23. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T et al. (2002) Endotoxin
can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
Int Immunol 14: 695–700.
24. Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR et al. (2007) The
vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Science 316: 1628–1632.
25. Inoue J, Aramaki Y (2007) Toll-like receptor-9 expression induced by tape-
stripping triggers on effective immune response with CpG-oligodeoxynucleo-
tides. Vaccine 25: 1007–1013.
26. Inoue J, Aramaki Y (2007) Suppression of skin lesions by transdermal application
of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic
dermatitis. J Immunol 178: 584–591.
27. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y (2005) Changes in
immune responses to antigen applied to tape-stripped skin with CpG-
oligodeoxynucleotide in mice. J Control Release 108: 294–305.
28. Inoue J, Aramaki Y (2007) Cyclooxygenase-2 inhibition promotes enhancement
of antitumor responses by transcutaneous vaccination with cytosine-phosphate-
guanosine-oligodeoxynucleotides and model tumor antigen. J Invest Dermatol
127: 614–621.
29. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y (2005) Changes in
immune responses to antigen applied to tape-stripped skin with CpG-
oligodeoxynucleotide in NC/Nga mice. Pharm Res 22: 1627–1633.
30. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y (2006) Changes in
immune responses to mite antigen sensitized through barrier-disrupted skin with
CpG-oligodeoxynucleotide in mice. Biol Pharm Bull 29: 385–387.
31. Poussin C, Foti M, Carpentier JL, Pugin J (1998) CD14-dependent endotoxin
internalization via a macropinocytic pathway. J Biol Chem 273: 20285–20291.
32. Kitchens RL, Wang P, Munford RS (1998) Bacterial lipopolysaccharide can
enter monocytes via two CD14-dependent pathways. J Immunol 161: 5534–
5545.
33. Kirkham M, Fujita A, Chadda R, Nixon SJ, Kurzchalia TV et al. (2005)
Ultrastructural identification of uncoated caveolin-independent early endocytic
vehicles. J Cell Biol 168: 465–476.
34. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S (2001) Endotoxin-
induced maturation of MyD88-deficient dendritic cells. J Immunol 166: 5688–
5694.
35. Gangloff SC, Za¨hringer U, Blondin C, Guenounou M, Silver J et al. (2005)
Influence of CD14 on ligand interactions between lipopolysaccharide and its
receptor complex. J Immunol 175: 3940–3945.
36. Felgner PL (1991) Cationic liposome-mediated transfection with lipofectinTM
reagent. Methods Mol Biol 7: 81–89.
37. Legendre JY, Szoka FC Jr (1992) Delivery of plasmid DNA into mammalian cell
lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm
Res 9: 1235–1242.
38. Morgan JR, Williams KE (1980) Preparation and properties of liposome-
associated gentamicin. Antimicrob Agents Chemother. 17: 544–548.
39. Inoue J, Ideue R, Takahashi D, Kubota M, Kumazawa Y (2009) Liposomal
glycosphingolipids activate natural killer T cell-mediated immune responses
through the endosomal pathway. J Control Release 133: 18–23.
40. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T et al. (2005)
Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I
interferon induction. Nature 434: 1035–1040.
Liposomal LPS Activate Only TRIF-Dependent Pathway
PLOS ONE | www.plosone.org 7 April 2013 | Volume 8 | Issue 4 | e60078
